Cost-Effectiveness Analysis of Budesonide/Formoterol and Fluticasone/Salmeterol for Stable Chronic Obstructive Lung Disease. J Respirol Indones [Internet]. 2022 Oct. 21 [cited 2025 Jul. 4];42(4):289–297. Available from: http://www.jurnalrespirologi.org/index.php/jri/article/view/378